Gainers
Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
Based on current demand and supply conditions, the Company expects:
2023 revenue to be in the range of $35 million to $50 million
2023 vehicle and powertrain sales to be in the range of 300 to 400